Status:

RECRUITING

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

Lead Sponsor:

Hillel Yaffe Medical Center

Conditions:

IVF

Endometrioma

Eligibility:

FEMALE

18-41 years

Brief Summary

Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic p...

Detailed Description

Endometriosis is a disease of the female reproductive system in which cells similar to those in the endometrium grow outside the uterus. Endometriosis prevalence is estimated to be around 10%, and eve...

Eligibility Criteria

Inclusion

  • A woman with endometrioma with a diameter of 25-100 mm

Exclusion

  • Other causes of infertility (sperm disorder, ovulation disorder, uterine disorder, mechanical factor, poor ovarian reserve)

Key Trial Info

Start Date :

August 9 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06971458

Start Date

August 9 2022

End Date

December 31 2027

Last Update

May 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hillel Yaffe Medical Center

Hadera, Israel